Glutamatergic dysfunction is associated with phenotypes of VGF-overexpressing mice

Exp Brain Res. 2022 Aug;240(7-8):2051-2060. doi: 10.1007/s00221-022-06384-w. Epub 2022 May 19.

Abstract

VGF nerve growth factor inducible (VGF) is a neuropeptide precursor, which is induced by several neurotrophic factors, including nerve growth factor and brain-derived neurotrophic factor. Clinically, an upregulation of VGF levels has been reported in the cerebrospinal fluid and prefrontal cortex of patients with schizophrenia. In our previous study, mice overexpressing VGF exhibited schizophrenia-related behaviors. In the current study, we characterized the biochemical changes in the brains of VGF-overexpressing mice. Metabolomics analysis of neurotransmitters revealed that glutamic acid and N-acetyl-L-aspartic acid were increased in the striatum of VGF-overexpressing mice. Additionally, the present study revealed that MK-801, which causes the disturbance in glutamic acid metabolism, increased the expression level of VGF-derived peptide (NAPP129, named VGF20), and VGF-overexpressing mice had higher sensitivity to MK-801. These results suggest that VGF may modulate the regulation of glutamic acid levels and the degree of glutamic acid signaling.

Keywords: Glutamic acid; MK-801; Schizophrenia; VGF nerve growth factor inducible.

MeSH terms

  • Animals
  • Dizocilpine Maleate* / pharmacology
  • Glutamic Acid
  • Mice
  • Phenotype
  • Prefrontal Cortex / metabolism
  • Schizophrenia* / genetics

Substances

  • Glutamic Acid
  • Dizocilpine Maleate